Valneva is the famous Corporate Investor, which was founded in 2013. The main office of represented Corporate Investor is situated in the Saint-herblain. The company was established in Europe in France.
The standard case for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are Kurma Partners, Idinvest Partners. In the next rounds fund is usually obtained by Idinvest Partners.
Among the most popular portfolio startups of the fund, we may highlight BliNK Biomedical. Among the most successful fund investment fields, there are Life Science, Biotechnology. For fund there is a match between the location of its establishment and the land of its numerous investments - France.
The top activity for fund was in 2014. The usual things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in less than 2 deals per year.
Related Funds
Fund Name | Location |
Bioclub | China, Hangzhou, Zhejiang |
Boston Syndicates (BOSS) | Boston, Massachusetts, United States |
Central Coast Angels | California, Santa Cruz, United States |
Central Wisconsin Angel Investors | Madison, United States, Wisconsin |
Currie Capital | California, San Francisco, United States |
D2 Communications | Hokkaido Prefecture, Japan, Sapporo |
Finn Capital Partners | California, San Francisco, United States |
Finn Partners | New York, New York, United States |
Gaohe Chuangtou | China, Hubei, Wuhan |
Jiahesheng Maoyi | China, Fujian, Zhangpu |
MyBey Ventures | - |
Oaktree Specialty Lending Corp. | New York, United States, White Plains |
PLG Ventures | California, Santa Monica, United States |
Shanhua Touzi | China, Guangdong, Guangzhou |
SINOCHEM GROUP | Beijing, Beijing, China |
Sundaram Mutual Fund | Chennai, India, Tamil Nadu |
Taiwan Development Fund | - |
Underground Printing | Ann Arbor, Michigan, United States |
Vidici Ventures | Stockholm, Stockholm County, Sweden |
Weintraub Capital Management | California, San Francisco, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
BliNK Biomedical | $4M | 11 Dec 2014 | Lyon, Auvergne-Rhône-Alpes, France |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
BliNK Biomedical | $4M | 11 Dec 2014 | Lyon, Auvergne-Rhône-Alpes, France |